Cryogenic Storage Of IV Bags For Cell And Gene Therapies

The rapid growth of the Cell and Gene Therapy (CGT) market brings unique challenges in packaging and storage. Cryo Bags, commonly used for these advanced therapies, face extreme conditions during cryogenic storage that can cause brittleness, shrinkage, and leaks—compromising product safety and efficacy. Ensuring container closure integrity (CCI) is critical to prevent contamination and maintain therapeutic value. Vacuum decay technology offers a sensitive, nondestructive solution capable of detecting leaks as small as 20 microns, even under harsh cryogenic conditions. This approach provides confidence in packaging performance and safeguards high-value CGT products during storage and transport.
Explore how vacuum decay testing addresses these risks and supports the reliability of cryogenic packaging in a rapidly expanding industry.
Get unlimited access to:
Enter your credentials below to log in. Not yet a member of Pharmaceutical Online? Subscribe today.